Normal view MARC view ISBD view

Outcomes and Safety of Suprapubic vs Urethral Catheterization Following Pelvic Fascia Sparing Robotic Prostatectomy.

MedStar author(s):

Citation: Urology Practice. :101097UPJ0000000000000492, 2023 Dec 05PMID: 38051298Department: MedStar Georgetown University Hospital/MedStar Washington Hospital Center | Urology Residency - CategoricalForm of publication: Journal ArticleMedline article type(s): Journal ArticleSubject headings: IN PROCESS -- NOT YET INDEXEDYear: 2023 ISSN:

2352-0779

Name of journal: Urology practiceAbstract: CONCLUSIONS: SPC after PFS-RARP is a safe and feasible alternative to UC. SPC is associated with an earlier return to continence and a greater likelihood of continence rates at catheter removal. Use of SPC may increase overall patient satisfaction following PFS-RARP.INTRODUCTION: Urethral catheter (UC) discomfort remains a burden following robotic-assisted radical prostatectomy (RARP). Suprapubic catheters (SPC) may reduce patient discomfort and increase satisfaction. Pelvic Fascia Sparing RARP (PFS-RARP) reduces the technical challenges of intra-operative SPC placement. We examined postoperative outcomes of SPC vs UC placement following PFS-RARP.METHODS: We conducted a retrospective review of a prospective IRB-approved database of PFS-RARP patients from June 2020 to December 2022 receiving SPC (n = 108) or UC (n = 104) postoperatively. Demographics, clinical, and perioperative outcomes were captured. Postoperative patient-reported quality of life was measured using Expanded Prostate Cancer Index Composite for Clinical Practice (EPIC-CP). Patients with intraoperative complications, intraoperative leaks, or undergoing salvage prostatectomy were excluded. Univariate and multivariate regression analyses were performed to compare outcomes.RESULTS: No significant differences in demographics or oncologic outcomes existed. There were no differences in complications, including urethral stricture or anastomotic leak. Men receiving SPC vs UC had earlier return to continence (7 v. 16 days, P < .001) and higher continence rates at catheter removal (67.6% v. 43.3%, P = .0003). On adjusted analyses, SPC was an independent predictor of continence at catheter removal (OR 2.21, P = .023). There were no differences between groups in preoperative or postoperative EPIC-CP scores, including no differences in postoperative quality of life (P = .46).All authors: Engelsgjerd S, Kodres-O'Brien S, Choudhury E, Garijo BM, Mason JB, Kowalczyk KJFiscal year: FY2024 Digital Object Identifier:

https://dx.doi.org/10.1097/UPJ.0000000000000492

Date added to catalog: 2024-01-22

Holdings ( 1 )
Title notes ( 5 )

Holdings
Item type	Current library	Collection	Call number	Status	Date due	Barcode
Journal Article	MedStar Authors Catalog	Article	38051298	Available		38051298

CONCLUSIONS: SPC after PFS-RARP is a safe and feasible alternative to UC. SPC is associated with an earlier return to continence and a greater likelihood of continence rates at catheter removal. Use of SPC may increase overall patient satisfaction following PFS-RARP.

INTRODUCTION: Urethral catheter (UC) discomfort remains a burden following robotic-assisted radical prostatectomy (RARP). Suprapubic catheters (SPC) may reduce patient discomfort and increase satisfaction. Pelvic Fascia Sparing RARP (PFS-RARP) reduces the technical challenges of intra-operative SPC placement. We examined postoperative outcomes of SPC vs UC placement following PFS-RARP.

METHODS: We conducted a retrospective review of a prospective IRB-approved database of PFS-RARP patients from June 2020 to December 2022 receiving SPC (n = 108) or UC (n = 104) postoperatively. Demographics, clinical, and perioperative outcomes were captured. Postoperative patient-reported quality of life was measured using Expanded Prostate Cancer Index Composite for Clinical Practice (EPIC-CP). Patients with intraoperative complications, intraoperative leaks, or undergoing salvage prostatectomy were excluded. Univariate and multivariate regression analyses were performed to compare outcomes.

RESULTS: No significant differences in demographics or oncologic outcomes existed. There were no differences in complications, including urethral stricture or anastomotic leak. Men receiving SPC vs UC had earlier return to continence (7 v. 16 days, P < .001) and higher continence rates at catheter removal (67.6% v. 43.3%, P = .0003). On adjusted analyses, SPC was an independent predictor of continence at catheter removal (OR 2.21, P = .023). There were no differences between groups in preoperative or postoperative EPIC-CP scores, including no differences in postoperative quality of life (P = .46).

English